These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14648724)

  • 1. Ischaemia-reperfusion is an event triggered by immune complexes and complement.
    Chan RK; Ibrahim SI; Verna N; Carroll M; Moore FD; Hechtman HB
    Br J Surg; 2003 Dec; 90(12):1470-8. PubMed ID: 14648724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS; Skehan JD; Thrane PS
    Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of complement and perspectives for intervention in transplantation.
    Chen G; Chen S; Chen X
    Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.
    Duehrkop C; Rieben R
    Biochem Pharmacol; 2014 Mar; 88(1):12-22. PubMed ID: 24384116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reperfusion syndrome: cellular mechanisms of microvascular dysfunction and potential therapeutic strategies.
    Girn HR; Ahilathirunayagam S; Mavor AI; Homer-Vanniasinkam S
    Vasc Endovascular Surg; 2007; 41(4):277-93. PubMed ID: 17704330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology of ischaemia-reperfusion injury].
    Sirotković-Skerlev M; Plestina S; Bilić I; Kovac Z
    Lijec Vjesn; 2006; 128(3-4):87-95. PubMed ID: 16808098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of ischaemia-reperfusion on the blood vessel.
    Gourdin MJ; Bree B; De Kock M
    Eur J Anaesthesiol; 2009 Jul; 26(7):537-47. PubMed ID: 19412112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells.
    Ferguson AR; Youd ME; Corley RB
    Int Immunol; 2004 Oct; 16(10):1411-22. PubMed ID: 15326094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for targeting complement inhibitors in ischaemia/reperfusion injury.
    Dong J; Pratt JR; Smith RA; Dodd I; Sacks SH
    Mol Immunol; 1999; 36(13-14):957-63. PubMed ID: 10698350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural antibody mediated innate autoimmune response.
    Zhang M; Carroll MC
    Mol Immunol; 2007 Jan; 44(1-3):103-10. PubMed ID: 16876247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reperfusion injury to skeletal muscle affects primarily type II muscle fibers.
    Chan RK; Austen WG; Ibrahim S; Ding GY; Verna N; Hechtman HB; Moore FD
    J Surg Res; 2004 Nov; 122(1):54-60. PubMed ID: 15522315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM.
    Austen WG; Zhang M; Chan R; Friend D; Hechtman HB; Carroll MC; Moore FD
    Surgery; 2004 Aug; 136(2):401-6. PubMed ID: 15300207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.
    Keshavjee S; Davis RD; Zamora MR; de Perrot M; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):423-8. PubMed ID: 15678055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM binding to injured tissue precedes complement activation during skeletal muscle ischemia-reperfusion.
    Chan RK; Ding G; Verna N; Ibrahim S; Oakes S; Austen WG; Hechtman HB; Moore FD
    J Surg Res; 2004 Nov; 122(1):29-35. PubMed ID: 15522311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury.
    Lee H; Green DJ; Lai L; Hou YJ; Jensenius JC; Liu D; Cheong C; Park CG; Zhang M
    Mol Immunol; 2010 Feb; 47(5):972-81. PubMed ID: 20004473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular ischaemia and reperfusion injury.
    Eltzschig HK; Collard CD
    Br Med Bull; 2004; 70():71-86. PubMed ID: 15494470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of the complement-fixing ability of recipient presensitization against HLA antigens.
    Bartel G; Wahrmann M; Exner M; Regele H; Schillinger M; Hörl WH; Böhmig GA
    Transplantation; 2007 Mar; 83(6):727-33. PubMed ID: 17414705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia-mediated aggregation of the actin cytoskeleton is one of the major initial events resulting in ischemia-reperfusion injury.
    Shi T; Moulton VR; Lapchak PH; Deng GM; Dalle Lucca JJ; Tsokos GC
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G339-47. PubMed ID: 19095765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate autoimmunity.
    Carroll MC; Holers VM
    Adv Immunol; 2005; 86():137-57. PubMed ID: 15705421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of complement activation following oxidative stress. In vitro and in vivo observations.
    Hart ML; Walsh MC; Stahl GL
    Mol Immunol; 2004 Jun; 41(2-3):165-71. PubMed ID: 15159062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.